LSBio
Products
  • Antibodies
  • All Antibodies
  • Primary Antibodies
  • Secondary Antibodies
  • IHC-plus Antibodies
  • Isotype Control Antibodies
  • ELISA and Assay Kits
  • All Kits
  • Assay Kits
  • Traditional ELISA Kits
  • Cell-Based ELISA Kits
  • DNA-Binding ELISA Kits
  • Phospho-Specific ELISA Kits
  • ELISA Development Kits
  • Chemiluminescent CLIA Kits
  • Proteins
  • All Proteins
  • Recombinant Proteins
  • Native Proteins
  • Over-expression Lysates
  • Cell and Tissue Lysates
  • Bio-active Proteins
  • Animal-free Proteins
  • Synthetic Peptides
  • Biochemicals
  • All Biochemicals

  • Immunohistochemistry
  • Comprehensive IHC Reports
  • Custom IHC Services
  • TCR Screening Services
  • IHC-plus Antibodies
Services
  • Immunohistochemistry Services

  • Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting immunostaining in relation to complex human pathologies.

  • TCR Screening Services

  • Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding. Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
Have a question? CustomerSupport@LSBio.com
Resources
  • Purchasing
  • Product Ordering Terms and Conditions
  • Holiday Schedule
  • About the LSBio Guarantee
  • About Our Rewards Program
  • Reference Material
  • About LSBio (LifeSpan BioSciences Inc.)
  • About Our 2-million Specimen Tissue Bank
  • About Our IHC Validation Process
  • About Our IHC-plus™ Immunohistochemistry Protocol
  • Protocols
  • Secure Logins
  • Login to Our Secure ShareFile Site
  • Login to Our IHC Database
Distributors
Contact Us

LSBio
2401 Fourth Avenue Suite 900
Seattle WA 98121

Phone: 866-819-4732 (Toll Free North America)
206-374-1102 (International)

Fax: 866-206-6909 (Toll Free North America)
206-577-4565 (International)
How to Buy - Details about how to buy our products.

Orders@LSBio.com - To submit a new order.

Customer.Support@LSBio.com - To submit questions about existing orders, pricing, availability, bulk quotes, proforma invoice requests, or other billing issues.

Technical.Support@LSBio.com - To request technical information requests about an LSBio product or its application.

Sales@LSBio.com - To request information about fee-for-service contract IHC studies, IHC reports, distribution agreements, or general business development.

Worldwide Distributors List - To find your local distributor if you're not within the United States.
Login ▾
Wish List
View Cart

LSBio Biochemicals

Assay Kit Image
Featured product categories including agonists, antagonists, inhibitors and modulators for your biomedical research needs. High quality products are available for use in cancer research, cardiovascular disease, cell biology, lipid research, immunology, metabolism, neuroscience, oxidative injury, and toxicology.


Alphabetical Listing

Catalog No. CAS Number Product Name Biological Function Purity
LS-H22 (±)5(6)-EET Ethanolamide CB2 agonist ≥95%
LS-H29 362519-49-1 (±)-SLV 319 CB1 receptor antagonist ≥98%
LS-H5 1217471-69-6 (2S)-OMPT LPA3 agonist ≥98%
LS-H30 656827-86-0 (R)-SLV 319 CB1 receptor antagonist ≥98%
LS-H133 29122-68-7 (R,S)-Atenolol Beta 1-adrenergic receptor antagonist ≥98%
LS-H134 839971 (S)-(-)-Propranolol (hydrochloride) Beta-adrenergic receptor antagonist ≥98%
LS-H14 451462-58-1 (S)-H-1152 (hydrochloride) ROCK inhibitor ≥95%
LS-H27 464213-10-3 (S)-SLV 319 CB1 receptor antagonist ≥98%
LS-H88 57333-96-7 1,24-dihydroxy Vitamin D3 Vitamin D receptor agonist ≥98%
LS-H76 60133-18-8 1,25-dihydroxy Vitamin D2 Vitamin D receptor agonist ≥98%
LS-H158 17735-98-7 13Z,16Z-Docosadienoic Acid FFAR4 agonist ≥98%
LS-H73 773825-80-2 16(R)-AFP 07 (free acid) IP receptor agonist ≥98%
LS-H86 54573-75-0 1-hydroxy Vitamin D2 Vitamin D receptor agonist ≥98%
LS-H89 41294-56-8 1-hydroxy Vitamin D3 Vitamin D receptor agonist ≥95%
LS-H72 103909-75-7 22-Oxacalcitriol Vitamin D receptor agonist ≥95%
LS-H87 21343-40-8 25-hydroxy Vitamin D2 Vitamin D receptor agonist ≥98%
LS-H144 133240-06-9 2-Ethyl-5,7-dimethyl-3H-imidazo[4,5-b]pyridine Angiotensin II receptor antagonist ≥98%
LS-H19 1224443-96-2 3-methoxy Limaprost FP receptor antagonist ≥98%
LS-H48 24386-93-4 5-Iodotubercidin ERK2 inhibitor ≥95%
LS-H145 83797-69-7 6-OAU GPR84 agonist ≥98%
LS-H74 64907-22-8 7α,25-dihydroxy Cholesterol GPR183 agonist ≥95%
LS-H109 93839-89-5 Adenosine 5'-(γ-thio)-triphosphate (lithium salt) P2Y2 receptor agonist, P2Y11 agonist ≥90%
LS-H59 210580-75-9 AL 34662 5-HT2 receptor agonist ≥98%
LS-H10 202463-68-1 AM281 CB1 receptor antagonist ≥98%
LS-H117 102121-60-8 AM580 RAR alpha agonist ≥98%
LS-H143 832714-46-2 APD668 GPR119 agonist ≥98%
LS-H140 1798310-55-0 AR420626 FFAR3 agonist, GPR41 agonist ≥95%
LS-H71 330981-72-1 AS-1269574 GPR119 agonist ≥98%
LS-H69 712313-33-2 BayCysLT2 CysLT2 receptor antagonist ≥95%
LS-H160 116673-45-1 Bis-(3,4,5-trimethoxyphenyl)-1,3-dioxolane PAF receptor antagonist ≥98%
LS-H32 112828-00-9 Calcipotriol (hydrate) Vitamin D receptor agonist ≥98%
LS-H153 107430-66-0 CD1530 Retinoid X receptor agonist ≥98%
LS-H90 522629-08-9 CGP 57380 TLR2 agonist ≥95%
LS-H116 834903-43-4 CID16020046 GPR55 antagonist ≥98%
LS-H83 264233-05-8 CID-2745687 GPR35 antagonist ≥95%
LS-H102 14976-57-9 Clemastine (fumarate) Histamin H1 receptor antagonist ≥98%
LS-H54 145231-35-2 Clobenpropit (hydrobromide) Histamine H3 receptor antagonist ≥98%
LS-H11 117048-59-6 Combrestatin A4 Tubulin polymerization inhibitor ≥98%
LS-H12 168555-66-6 Combrestatin A4 3'-O-Phosphate (sodium salt) Tubulin polymerization inhibitor ≥98%
LS-H150 193825-78-4 Commendamide GPR132 agonist ≥95%
LS-H154 383432-38-0 CP 724,714 HER2 inhibitor ≥95%
LS-H104 1345858-76-5 CYM 50308 SIP4 agonist ≥98%
LS-H114 945128-26-7 CYM 5541 S1P3 agonist ≥98%
LS-H98 79055-68-8 D-AP5 NMDA receptor antagonist ≥95%
LS-H155 346692-04-4 DC260126 GPR40 antagonist ≥98%
LS-H9 56-53-1 Diethylstilbestrol Estrogen receptor agonist ≥98%
LS-H99 76326-31-3 DL-AP5 NMDA receptor antagonist ≥95%
LS-H77 144143-96-4 Eprosartan (mesylate) AT1 receptor antagonist ≥98%
LS-H37 63177-57-1 Erbstatin analog EGFR inhibitor ≥98%
LS-H135 13636-18-5 Fendiline (hydrochloride) Alpha 2-adrenergic receptor antagonist ≥95%
LS-H82 162359-55-9 Fingolimod S1P1 receptor agonist, S1P4 receptor agonist, S1P5 receptor agonist ≥98%
LS-H26 881639-98-1 G-1 GPR30 agonist ≥98%
LS-H105 1161002-05-6 G-15 GPER antagonist ≥95%
LS-H96 1392487-51-2 G-36 GPER antagonist ≥98%
LS-H163 31450-14-3 Gamma-Linolenic Acid ethyl ester LTB4 receptor antagonist ≥98%
LS-H58 201738-24-1 Glycerophospho-N-Oleoyl Ethanolamine PPAR alpha agonist ≥98%
LS-H129 1599477-75-4 GPR120 Compound A GPR120 agonist ≥98%
LS-H80 870554-67-9 GQ-16 PPAR gamma agonist ≥98%
LS-H137 80557-12-6 Grifolic Acid GPR120 agonist ≥95%
LS-H123 300833-95-8 GSA 10 SMO agonist ≥95%
LS-H146 349085-82-1 GSK137647A GPR120 agonist ≥98%
LS-H25 306974-70-9 GW 1100 GPR40 antagonist ≥95%
LS-H67 405911-17-3 GW 3965 (hydrochloride) LXR alpha agonist, LXR beta agonist ≥98%
LS-H3 317318-70-0 GW 501516 PPAR delta agonist ≥98%
LS-H46 220904-83-6 GW 5074 Raf-1 inhibitor ≥98%
LS-H23 265129-71-3 GW 7647 PPAR alpha agonist ≥98%
LS-H47 666260-75-9 GW 842166X CB2 receptor agonist ≥98%
LS-H50 612831-24-0 GW 848687X EP1 receptor antagonist ≥98%
LS-H24 885101-89-3 GW 9508 GPR40 agonist, GPR120 agonist ≥98%
LS-H56 247923-29-1 GW 9578 PPAR alpha agonist ≥98%
LS-H103 139262-76-3 H2L5186303 LPA2 receptor antagonist ≥98%
LS-H70 712313-35-4 HAMI3379 CysLT2 receptor antagonist ≥90%
LS-H164 183387-50-0 HE-3235 Androgen receptor antagonist ≥95%
LS-H115 306935-41-1 IPBT-5CA GPR109B agonist ≥98%
LS-H64 925239-03-8 JMV3002 Ghrelin receptor antagonist ≥98%
LS-H62 459168-41-3 JNJ-7777120 Histamin H4 receptor antagonist ≥98%
LS-H31 383150-41-2 JTE-013 S1P1 receptor antagonist ≥98%
LS-H63 355025-24-0 Ki16425 LPA receptor antagonist ≥95%
LS-H149 228559-41-9 Ki8751 VEGFR2 inhibitor ≥98%
LS-H118 1628759-75-0 KMN-80 EP4 agonist ≥98%
LS-H60 147776-06-5 L-161,982 EP4 receptor antagonist ≥95%
LS-H75 244101-02-8 L-798,106 EP3 receptor antagonist ≥95%
LS-H38 244240-24-2 LFM-A13 BTK inhibitor, PLK inhibitor ≥98%
LS-H156 434-13-9 Lithocholic Acid Vitamin D receptor agonist ≥95%
LS-H120 79794-75-5 Loratadine H1 receptor agonist ≥98%
LS-H8 124750-99-8 Losartan (potassium salt) AT1 receptor antagonist ≥98%
LS-H39 75330-75-5 Lovastatin HMG-CoA reductase inhibitor ≥98%
LS-H40 75225-50-2 Lovastatin Hydroxy Acid (sodium salt) HMG-CoA reductase inhibitor ≥98%
LS-H141 862901-87-9 LT175 PPAR alpha agonist, PPAR gamma agonist, ≥98%
LS-H35 117423-74-2 LY223982 BLT1 receptor antagonist ≥98%
LS-H124 130798-51-5 MDL 29951 NMDA receptor antagonist ≥98%
LS-H41 73573-88-3 Mevastatin HMG-CoA reductase inhibitor ≥98%
LS-H121 915191-42-3 MF498 EP4 receptor antagonist ≥98%
LS-H33 571170-77-9 MK-0524 DP1 receptor antagonist ≥98%
LS-H66 115104-28-4 MK-571 CysLT2 receptor antagonist ≥95%
LS-H161 115103-85-0 MK-571 (sodium salt) CysLT1 receptor antagonist ≥95%
LS-H110 852230-33-2 ML-031 S1P2 agonist ≥95%
LS-H111 1883548-87-5 ML-179 LRH-1 agonist ≥98%
LS-H112 863588-32-3 ML-180 LRH-1 agonist ≥98%
LS-H142 794572-10-4 ML-184 CB1 antagonist, CB2 antagonist ≥98%
LS-H113 713121-80-3 ML-193 GPR55 antagonist ≥98%
LS-H17 151767-02-1 Montelukast (sodium salt) CysLT1 receptor antagonist ≥98%
LS-H2 494844-07-4 NESS 0327 CB1 antagonist ≥98%
LS-H151 1599432-08-2 NIBR189 EBI2 antagonist ≥98%
LS-H7 791122-48-0 NO-Losartan A AT1 receptor antagonist ≥97%
LS-H4 85075-82-7 Oleoyl Ethyl Amide FAAH inhibitor ≥98%
LS-H157 936889-68-8 OXA-01 mTORC1 inhibitor, mTORC2 inhibitor ≥98%
LS-H147 131918-61-1 Paricalcitol Vitamin D receptor agonist ≥98%
LS-H148 100299-08-9 Pemirolast (potassium salt) Histamine H1 receptor antagonist ≥98%
LS-H51 898235-65-9 PF-622 FAAH inhibitor >98%
LS-H52 959151-50-9 PF-750 FAAH inhibitor >98%
LS-H101 1227301-51-0 Philanthotoxin 74 (hydrochloride) AMPA receptor antagonist ≥98%
LS-H18 103177-37-3 Pranlukast CysLT1 receptor antagonist ≥98%
LS-H42 81093-37-0 Pravastatin HMG-CoA reductase inhibitor ≥98%
LS-H43 81131-70-6 Pravastatin (sodium salt) HMG-CoA reductase inhibitor ≥98%
LS-H127 58-33-3 Promethazine (hydrochloride) Histamine H1 receptor antagonist ≥95%
LS-H61 Propenyl-L-NIO (hydrochloride) iNOS inhibitor ≥90%
LS-H20 388575-52-8 PSN375963 PPAR alpha agonist ≥98%
LS-H21 857652-30-3 PSN632408 PPAR alpha agonist ≥98%
LS-H94 141400-58-0 PX 12 Thioredoxin 1 inhibitor ≥98%
LS-H108 89-00-9 Quinolinic Acid NMDA receptor agonist ≥98%
LS-H53 24003-58-5 QX-314 (bromide) TRPV1 receptor agonist ≥98%
LS-H138 84225-95-6 Raclopride Dopamine D2 receptor antagonist ≥99%
LS-H152 313348-27-5 Regadenoson Adenosine A2 receptor agonist ≥98%
LS-H93 256382-08-8 Rivenprost EP4 receptor agonist ≥98%
LS-H1 209268-36-0 S-5751 DP1 antagonist ≥95%
LS-H107 304909-07-7 SANT 1 SAG agonist ≥98%
LS-H49 152121-30-7 SB 202190 p38 MAP kinases ≥98%
LS-H68 1049747-87-6 SB-242084 (hydrochloride) 5-HT2C receptor agonist ≥98%
LS-H44 79902-63-9 Simvastatin HMG-CoA reductase inhibitor ≥98%
LS-H97 14513-15-6 SIRT1/2 Inhibitor IV SIRT1 inhibitor, SIRT2 inhibitor ≥98%
LS-H15 869998-49-2 SPD-304 TNF alpha inhibitor ≥98%
LS-H84 SR 1555 (hydrochloride) ROR gamma agonist ≥98%
LS-H85 293753-05-6 SR 3335 ROR alpha agonist ≥95%
LS-H125 218156-96-8 SRPIN340 SRPK1 inhibitor ≥98%
LS-H126 168835-82-3 SU 1498 VEGFR2 inhibitor ≥98%
LS-H91 204005-46-9 SU 5416 VEGFR2 inhibitor, KDR inhibitor, FLK1 inhibitor ≥98%
LS-H106 60325-46-4 Sulprostone EP3 receptor agonist ≥98%
LS-H100 103628-48-4 Sumatriptan (succinate) 5-HT1 receptor agonist ≥98%
LS-H65 313516-66-4 T0070907 PPAR gamma receptor agonist ≥98%
LS-H136 1000413-72-8 TAK-875 FFAR1 agonist ≥95%
LS-H13 4671-75-4 Tetradecyl Phosphonate LPA1 antagonist ≥98%
LS-H95 20601-85-8 Tetrahydromagnolol GPR55 antagonist ≥98%
LS-H55 148440-81-7 Thioperamide (maleate) Histamine H3 receptor antagonist ≥98%
LS-H132 251310-57-3 Thyroid Hormone Receptor Antagonist (1-850) Thyroid hormone receptor antagonist ≥98%
LS-H131 1374516-07-0 TUG-891 GPR120 agonist ≥98%
LS-H119 28053-08-9 UDP-Glucose (sodium salt) P2Y14 receptor ligand, GPR17 ligand ≥98%
LS-H6 181695-72-7 Valdecoxib COX-2 inhibitor ≥98%
LS-H92 15966-93-5 VEGFR2 Kinase Inhibitor I VEGFR2 inhibitor, KDR inhibitor, FLK1 inhibitor ≥95%
LS-H79 67-97-0 Vitamin D3 Vitamin D receptor agonist ≥98%
LS-H28 909725-62-8 W146 (trifluoroacetate salt) S1P1 receptor antagonist ≥95%
LS-H81 1207064-61-6 WAY-208466 (hydrochloride) 5-HT6 receptor agonist ≥98%
LS-H57 947669-91-2 WWL70 ABHD6 inhibitor ≥97%
LS-H122 725247-18-7 XCT790 ERR alpha agonist ≥98%
LS-H16 107753-78-6 Zafirlukast CysLT1 receptor antagonist ≥97%
LS-H45 208260-29-1 ZM 336372 Raf-1 inhibitor >98%
LS-H165 506-26-3 γ-Linolenic Acid LTB4 receptor antagonist ≥98%

Get Social With Us! Follow us on Facebook Follow us on Google+ Follow us on LinkedIn PSL Alliance Member
Copyright © 2017 LifeSpan BioSciences, Inc. All Rights Reserved Privacy Policy
Catalog Number